Reports Of Autopsies In VAERS And Associated Adverse Events Linked To Cause Of Death DOI Open Access
Jessica Rose

Опубликована: Июль 27, 2024

Background: Since the roll-out of Pfizer-BioNTech BNT162b2, Moderna mRNA-1273, Janssen Ad26.COV2.S and Novavax COVID-19 injections in United States, millions individuals have reported adverse events (AEs) using Vaccine Adverse Events Reports System (VAERS).Objectives: To examine reports death VAERS associated with autopsy context injectable products Influenza vaccines for equivalent timeframes.Methods: data was used to frequency reporting general AES, specific AEs linked since beginning mass injection campaign - up including July 2024. product AE collected from 2021-2023, were compared vaccine 2018-2020, thus matching timeframes administration each product. The total number shots administered per type also calculated calculate rates million doses. Autopsy made association further examined fetal child deaths. In addition geographic locations mapped according ratios autopsies deaths state order visualize which states ordered most autopsies.Results: domestic following spanning 2021-2023 is 18 times higher than average timeframe 2018-2020. This represents a 1,714% increase absolute equal four versus twelve vaccines. age involving shot 53 whereas it 25 context. 69% all autopsy-linked cardiovascular AEs, more precisely, 11%, 12% 16% these are myocarditis, cardiac arrest pulmonary embolism (PE), respectively. Likewise regard percentage issues (67% total), but only 7% myocarditis; there no or embolism. rate decreased significantly (p = 0.03) by staggering 77.6% when indicating questionable discrepancy between standard request era.Conclusions: Statistically, significant difference comparing with. Despite fact that count reports, decrease (N=262) involve PE supports theory deterministic PE. Noteworthy, 67% (N=14) cardiovascular-related death, involvement

Язык: Английский

COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1 DOI
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger

и другие.

International Journal of Vaccine Theory Practice and Research, Год журнала: 2024, Номер 3(2), С. 1112 - 1178

Опубликована: Июнь 29, 2024

Our understanding of COVID-19 synthetic, modified mRNA (modmRNA) products and their public health impact has evolved substantially since December 2020. Published reports from the original randomized placebo-controlled trials concluded that modmRNA injections could greatly reduce symptoms. However, premature termination both obviated any reliable assessment potential adverse events due to an insufficient timeframe for proper safety evaluation. Following authorization global distribution, problems with methods execution have emerged. The usual testing protocols toxicology requirements were bypassed. Many key trial findings either misreported or omitted entirely published reports. By implication, secondary estimates excess morbidity mortality in must be deemed underestimates. Rigorous re-analyses data post-marketing surveillance studies indicate a substantial degree modmRNA-related harms than was initially reported. Confidential Pfizer documents had revealed 1.6 million by August 2022. A third serious injuries cardiovascular, neurological, thrombotic, immunological, reproductive systems, along alarming increase cancers. Moreover, well-designed shown repeated cause immune dysfunction, thereby potentially contributing heightened susceptibility SARS-CoV-2 infections increased risks COVID-19. This paper also discusses insidious influence Bio-Pharmaceutical Complex, closely coordinated collaboration between organizations, pharmaceutical companies, regulatory agencies. We recommend moratorium on until toxicological are conducted.

Язык: Английский

Процитировано

7

Clinical Approach to Post-acute Sequelae After COVID-19 Infection and Vaccination DOI Open Access
Nicolas Hulscher,

Brian C. Procter,

Cade Wynn

и другие.

Cureus, Год журнала: 2023, Номер unknown

Опубликована: Ноя. 21, 2023

The spike protein of SARS-CoV-2 has been found to exhibit pathogenic characteristics and be a possible cause post-acute sequelae after infection or COVID-19 vaccination. vaccines utilize modified, stabilized prefusion that may share similar toxic effects with its viral counterpart. aim this study is investigate mechanisms harm biological systems from vaccine-encoded propose mitigation strategies. We searched PubMed, Google Scholar, ‘grey literature’ find studies (1) investigated the on systems, (2) helped differentiate between vaccine-generated proteins, (3) identified detoxification protocols compounds had signals benefit acceptable safety profiles. abundant evidence damage in cardiovascular, hematological, neurological, respiratory, gastrointestinal, immunological systems. Viral proteins have shown play direct role cardiovascular thrombotic injuries both Detection for at least 6-15 months vaccination those indicates as primary contributing factor long COVID. rationalized these findings give support potential long-term post-infection and/or vaccine-induced complications. base protocol, composed oral nattokinase, bromelain, curcumin. This approach holds immense promise clinical care, upon which additional therapeutic agents are applied goal aiding resolution Large-scale, prospective, randomized, double-blind, placebo-controlled trials warranted order determine relative risks benefits protocol.

Язык: Английский

Процитировано

15

COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2 DOI Creative Commons
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose

и другие.

International Journal of Vaccine Theory Practice and Research, Год журнала: 2024, Номер 3(2), С. 1275 - 1344

Опубликована: Авг. 16, 2024

The COVID-19 modified mRNA (modmRNA) lipid nanoparticle-based “vaccines” are not classical antigen-based vaccines but instead prodrugs informed by gene therapy technology. Of considerable note, these products have been linked to atypical adverse and serious event profiles. As discussed in Part 1, health-related risks drawbacks were drastically misreported underreported the Pfizer Moderna trial evaluations of genetic products. Now 2, we examine main structural functional aspects injectables. modmRNA injectable introduce a unique set biological challenges human body with potential induce an extensive range adverse, crippling, life-threatening effects. Based on fact that there is no current method quantify host (cell-based) spike protein production vivo following injection prodrugs, standard “dose”. This part due differences output, which depends cell metabolism transfection efficiency. It therefore difficult predict profiles individual basis, considering millions adults across world reported severe events context products, valid concerns raised regarding infants younger age groups for whom poses only minimal risks. We address process-related impurities inherent mass posed contaminants. then categorize principal associated brief systems-based synopsis each six domains harms: (1) cardiovascular, (2) neurological, (3) hematologic; (4) immunological, (5) oncological, (6) reproductive. conclude discussion primary public health regulatory issues arising from this evidence-informed synthesis literature reiterate urgency imposing global moratorium modmRNA-LNP-based platform.

Язык: Английский

Процитировано

2

Reports Of Autopsies In VAERS And Associated Adverse Events Linked To Cause Of Death DOI Open Access
Jessica Rose

Опубликована: Июль 27, 2024

Background: Since the roll-out of Pfizer-BioNTech BNT162b2, Moderna mRNA-1273, Janssen Ad26.COV2.S and Novavax COVID-19 injections in United States, millions individuals have reported adverse events (AEs) using Vaccine Adverse Events Reports System (VAERS).Objectives: To examine reports death VAERS associated with autopsy context injectable products Influenza vaccines for equivalent timeframes.Methods: data was used to frequency reporting general AES, specific AEs linked since beginning mass injection campaign - up including July 2024. product AE collected from 2021-2023, were compared vaccine 2018-2020, thus matching timeframes administration each product. The total number shots administered per type also calculated calculate rates million doses. Autopsy made association further examined fetal child deaths. In addition geographic locations mapped according ratios autopsies deaths state order visualize which states ordered most autopsies.Results: domestic following spanning 2021-2023 is 18 times higher than average timeframe 2018-2020. This represents a 1,714% increase absolute equal four versus twelve vaccines. age involving shot 53 whereas it 25 context. 69% all autopsy-linked cardiovascular AEs, more precisely, 11%, 12% 16% these are myocarditis, cardiac arrest pulmonary embolism (PE), respectively. Likewise regard percentage issues (67% total), but only 7% myocarditis; there no or embolism. rate decreased significantly (p = 0.03) by staggering 77.6% when indicating questionable discrepancy between standard request era.Conclusions: Statistically, significant difference comparing with. Despite fact that count reports, decrease (N=262) involve PE supports theory deterministic PE. Noteworthy, 67% (N=14) cardiovascular-related death, involvement

Язык: Английский

Процитировано

0